Herve Berdou appointed as Piramal Pharma Solutions new Chief Operating Officer

Published On 2022-06-22 06:11 GMT   |   Update On 2022-06-22 06:11 GMT
Advertisement

Mumbai: Piramal Pharma Limited's Pharma Solutions business has announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma Solutions (PPS).

Berdou joins Piramal Pharma Solutions from Lonza, where he was the Global Head of Operations, Cell and Gene Technologies. He has more than two decades of experience across global supply chain, procurement, and operations, including manufacturing and site head positions at both small and large facilities. At Lonza, Berdou led a network of contract services sites across the globe. Prior to that, he worked with a number of well-respected pharmaceutical companies, including AstraZeneca & MedImmune and Novartis. His passion lies in building customer-centric strategies, creating lean organizations, engaging with employees through a robust and inclusive culture, and forming a strong quality mindset across the organization. For his new role, Berdou will be based in the Northeastern United States.

Advertisement
Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions, said, "I welcome Herve to PPS and wish him all the success in the new role. His broad, in-depth industry and functional expertise will help us create value for all our stakeholders as we continue our journey of profitable growth. His blend of CDMO and innovative pharmaceutical company experience positions him to understand and meet the needs of our customers and their patients. His multi-country operating track record will bring the best of our team and site network to our clients as we deliver integrated projects and support their clinical progression and commercial success. Herve's management style is aligned to our values and our cultural priorities."
Berdou holds a Master's (DESS) in Procurement and Supply Chain from IAE in Grenoble, France - Écoles Universitaires de Management, and a degree in Economics and Politics from Université Pierre Mendès-France.

Read also: Piramal Pharma Solutions expands API capabilities at Digwal site  

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News